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tivity of B apoprotein was maximal in very low density and low density lipoproteins 1 and 1k-h later, respectively, in a manner consistent with a precursor-product relationship. When protein-labeled very low density lipoproteins were injected into rats, the relationships of specific activity again indicated that B apoprotein of very low density lipoproteins may be the sole precursor of that of low density lipoproteins. However, less than 10% of the B apoprotein that disappeared from very low density lipoproteins appeared in low density lipoproteins. To evaluate the sites of removal of B apoprotein of very low density lipoproteins from plasma, protein-labeled very low density lipoproteins were incubated with unlabeled high density lipoproteins to reduce radioactivity in non-B apoproteins selectively by molecular exchange. Most of the B apoprotein was rapidly removed by the liver. The extensive hepatic uptake of both the cholesteryl ester and B apoprotein components of rat very low density lipoproteins may explain the characteristically low concentrations of plasma low density lipoproteins in the rat.
INTRODUCTION
The plasma low density lipoprotein (LDL)' of both humans (2, 3) and rats (4, 5) contains as its major protein component the B apoprotein also found in very low density lipoproteins (VLDL). Early studies by Gitlin et al. (6) with radioiodine-labeled VLDL demonstrated transfer of protein from VLDL to LDL in normal as well as nephrotic humans. More recently, similar studies in humans (7, 8) and in rats (9, 10) have shown that the iodine-labeled B apoprotein of VLDL is transfered to that of LDL.
Although these studies indicate that some of the B apoprotein of LDL is derived from that of VLDL, the quantitative aspects of this conversion remain uncertain. Thus, the fraction of radioiodine-labeled B apoprotein of VLDL converted to LDL is considerably smaller in the rat than in man (6, 7, 11) , but this could result from differing behavior of the modified protein in the two species. Also, these investigations have provided no information about the extent to which the B apoprotein of LDL arises from that of VLDL because specific activities of the protein were not measured. It is important to resolve these questions because of their bearing on the large species differences in concentration of LDL. Among mammals, rats have nearly the lowest and humans the highest levels.
In 
METHODS
Preparation of labeled lipoproteints. Experiments were conducted in the afternoon on nonfasting male SpragueDawley rats maintained on standard Purina rat chow (Ralston Purina Co., St. Louis, Mo.). 1-2 mCi of L-[4,5-3H] -lysine (Amersham/Searle Corp., Arlington Heights, Ill.), sp act 90 mCi/mmol, was dissolved in 0.15 M NaCl solution (saline) and injected into a tail vein. At selected intervals the rats were anesthetized with diethyl ether and bled from the abdominal aorta. Serum was obtained and centrifuged in the 40.3 rotor of a preparative ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.) at 10°C to separate the lipoprotein classes described below (13) . All lipoproteins were recentrifuged at their upper density limit and then dialyzed against saline except d < 1.006 lipoproteins to be injected into recipient rats.
For experiments involving analysis of 3H in tissue proteins, 3H in apoproteins other than the B apoprotein was reduced by molecular exchange. This was accomplished by mixing unlabeled HDL with VLDL prepared from rats injected with [3H] lysine 1 h before exsanguination. The ratio of protein in HDL to that in VLDL was about 10: 1. After incubation for 30 min at 370C, the mixture, containing 13-50 mg protein in a volume of less than 3 ml, was applied to a 1.2 X 90 cm column of 6% agarose gel (Bio-Rad Laboratories, Richmond, Calif.) that had been equilibrated with 0.2 M NaCl containing 1 mM EDTA at pH 7.0. The VLDL were eluted with this buffer in the void volume, uncontaminated by HDL, at a flow rate of 10 ml/h. VLDL prepared in this manner were injected into recipient rats within 42 h of the time that the donor rats were bled. These incubated VLDL had more cholesteryl esters than nonincubated VLDL (Table I) , but their electrophoretic mobility and content of TMU-insoluble protein and of TMUsoluble proteins were not altered. A band corresponding to the major HDL apoprotein could not be detected in the incubated VLDL by polyacrylamide gel electrophoresis. However, the percentage of densitometric area owing to the major slowly migrating (arginine-rich) protein was reduced from 35 to 28. These VLDL contained 86.3%o (SD 5.9) of the 3H in TMU-insoluble protein.
Injection of labeled lipoproteins into recipient rats. Labeled VLDL, containing about 0.25 mg protein in a volume of 0.75-1.00 ml, were injected into tail veins of recipient rats. Six to eight rats were injected with each preparation of VLDL and bled at selected intervals under diethyl ether anesthesia. Blood was allowed to clot or was mixed with EDTA, 1 mg/ml, and placed on ice, and the serum or plasma was treated as described above to separate lipoprotein classes. Selected organs were removed promptly and rinsed in saline. The small intestine was flushed with saline and the mucosa expressed with a spatula. The organs were frozen at -20°C until they were analyzed 2-3 days later.
Preparation and analysis of apoproteins. Solutions of recentrifuged and dialyzed lipoproteins (200-400 ul containing less than 1 mg protein/ml) were rapidly mixed in a 12 ml conical centrifuge tube with an equal volume of (14) . Chemical composition of lipoproteins was determined as described previously (12) .
Analysis of 'H. Lipoprotein solutions and samples of TMU-soluble and insoluble proteins were counted in either Protosol or Aquasol (New England Nuclear, Boston, Mass.). Efficiency of counting was determined with an internal standard of 'H20.
Samples of wet tissue weighing about 1 g were minced and extracted with 25 parts acetone-alcohol, 1: 1 (vol/vol), for 24 h at room temperature, and the insoluble material was collected on filter paper. This residue wvas dried and oxidized (17) VLDL containing an average of 86% of the 'H in TMU-insoluble fraction were used. Removal of this labeled protein from the plasma was rapid and the rate and extent of transfer of labeled TMU-insoluble protein to LDL were similar to those observed with VLDL not incubated with HDL (Table IV ). Most of injected 'H rapidly appeared in hepatic proteins. 15-min after injection, it amounted to 51% of the 'H injected and 58% of that removed from plasma VLDL. The other organs analyzed contained very small amounts of 'H. At early time points, recovery of 'H in these tissues and in blood plasma was about 78% of the amount injected. The specific activity of TMU-insoluble protein in VLDL and LDL was determined in two experiments in which labeled VLDL were injected; one with VLDL that had been incubated with HDL and one with unincubated VLDL. In both cases, the specific activity in LDL rose to equal that in VLDL after 30-60 min (Fig.   5 ), as in experiments in which ['H]lysine was injected. DISCUSSION As in man (14) , our results show that TMU selectively and quantitatively precipitates the B apoprotein in small samples of VLDL and LDL, greatly facilitating measurements of mass and radioactivity. Upon gel filtration in Sephadex G-150, the distribution of 'H in TMUinsoluble protein of VLDL corresponded to peak VS-1 of Bersot et al. (4) , and P1 of Koga et al. (5) , identified by them as the rat apoprotein corresponding to the B apoprotein. The amino acid composition of the TMUinsoluble protein in VLDL also resembled that obtained for the P1 peak of both VLDL and LDL by Koga et al. (5) . The biosynthetic tracer that we have used not only has theoretical advantages over tracers produced by derivatization, but it also labels VLDL-lipids to a lesser extent than the commonly used radioiodine.
Perfused livers of fed rats secrete substantial amounts of protein in VLDL (20, 21 (12) . This process folloN-s hydrolysis of component triglycerides of V-LDL in extrahepatic tissues, which results in formation of a remnant particle that retains all of the component B apoprotein and cholesteryl esters of VLDL but which is substantially depleted not only of triglycerides but also of much of its phospholipids and C apoproteins (18) . Thus, both a major apolar "core" component and a major polar "surface" component of remnant VLDL are rapidly removed by the liver. The hepatic uptake of component cholesteryl esters of VLDL is followed by gradual hydrolysis (12) , and our results suggest that the B apoprotein is also slowly degraded (Table IV) . "I-labeled VLDL apoprotein taken up by rat liver is initially coIncentrated at the cell surface, but gradually appears in the region of secondary lysosomes (23) . Therefore, it seems likely that rapid hepatic uptake is followed by gradual enzymatic degradation of both lipid and protein components. The actual mechanism of uptake remains to be determined, but the comparable uptake of core and surface components is clearly consistent with endocytosis of the entire particle. (25) . The rapid uptake by the liver of these two components of remnant VLDL is in striking contrast to these observatioins and suggests that a highly specific mechanism operates in liver as well.
Approximately as much VLDL B apoprotein was converted to LDL as was observed previously for cholesteryl esters (12) . However, in contrast to the B apoprotein, LDL derive their cholestervl esters in part from souirces other than VLDL, probably related to the action of lecithiin: cholesteryl acyl transferase.
The small fraction of B apoprotein of VLDL converted to LDL in the rat is consistent with their turnover times and pool sizes in the blood. Since the turnover times are on the order of 5.5 min and 130 min (10) , respectively, and w-e found that the pool sizes are approximately equal (Table II) , it follows that transport of B apoprotein in LDL is oily about 4A of that in VLDL.
The extenit to whlich B apoprotein of VLDL is removed by the liver or converted to LDL may varv colnsiderably among mlammnnals. In aduilt lhuimans, average intravascular pool sizes of apoprotein PB in VLDL aind LDL (for a plasma volume of 3,000 ml) are approximatelv 90 mg4 and 2,500 mg (26) and their turnover times are abotut 2 h (7) and 100 h (27) , respectively. This gives rates of transport of 45 and 25 mg/h for VLDL and LDL. If LDL are not secreted independently in man, it appears that a large fraction of the B protein in VLDL may be converted to LDL. This conclusion is supported by published data on the conversion of radioiodine-labeled apoprotein of VLDL to LDL (6, 7). Comparison of the approximately 15-fold difference in the fraction of B apoprotein of VLDL that is converted to LDL in rats and humans with the difference in ratio of B apoprotein concentration in the two lipoprotein classes (1: 1 in the rat and 25-30: 1 in man) indicates that the proportional use of the two pathways of catabolism of remnant VLDL evidently could be a major determinant of the gross differences in concentration of plasma LDL in the two species.
'Transport of B protein of VLDL in the two experiments shown in Fig. 5 
